IP Library Granted Patent US 12,622,642
Granted Patent B2
US 12,622,642 · App. 16/870,152 · Granted May 12, 2026

Patch-based physiological sensor

Inventors: Marshal Dhillon (San Diego, CA); Mark Dhillon (San Diego, CA); Erik Tang (San Diego, CA); Lauren Nicole Miller Hayward (La Jolla, CA); Matthew Banet (San Diego, CA); James McCanna (Pleasanton, CA)
Assignees: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
A61B5/6833A61B5/0024A61B5/02427A61B5/0295A61B5/0823A61B5/1455A61B5/316A61B5/318A61B5/6823A61B2560/0204
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,622,642
App. No.
16/870,152
Granted
May 12, 2026
Kind
B2
Abstract

A body-worn patch sensor for simultaneously measuring a blood pressure (BP), pulse oximetry (SpO2), and other vital signs and hemodynamic parameters from a patient featuring a sensing portion having a flexible housing that is worn entirely on the patient's chest and encloses a battery, wireless transmitter, and all the sensor's sensing and electronic components. It measures electrocardiogram (ECG), impedance plethysmogram (IPG), photoplethysmogram (PPG), and phonocardiogram (PCG) waveforms, and collectively processes these to determine the vital signs and hemodynamic parameters. The sensor that measures PPG waveforms also includes a heating element to increase perfusion of tissue on the chest.

Claims (38)

1 . A sensor for measuring a photoplethysmogram (PPG) waveform, a phonocardiogram (PCG) waveform, an impedance plethysmogram (IPG) waveform, and an electrocardiogram (ECG) waveform from a patient's chest, the sensor comprising:

a housing configured to be located on the patient's chest;

a reflective optical sensor for measuring the PPG waveform;

a digital microphone for measuring the PCG waveform;

a buzzer disposed in the housing, adjacent to the digital microphone, configured to generate an acoustic sound at a known amplitude and frequency;

a processor disposed within the housing; and

a set of electrodes that attach the optical sensor and the digital microphone to the patient's chest, with the set of electrodes connected to an ECG sensor configured to measure the ECG waveform,

wherein the set of electrodes is further attached to an IPG sensor, the IPG sensor configured to measure the IPG waveform,

wherein the IPG sensor is configured to inject current into the patient's chest, and further configured to measure the current to determine the IPG waveform,

wherein the digital microphone is configured to compare the acoustic sound generated by the buzzer with the PCG waveform to determine a quality of patient-sensor adhesion between the sensor and a surface of the patient's chest, and

wherein the processor uses time-domain analysis and frequency-domain analysis of the IPG waveform and uses time-domain analysis and frequency-domain analysis of the PCG waveform to collectively determine one of a coughing event, a wheezing event, and an apnea event by identifying amplitude modulation in the IPG waveform.

2 . The sensor of claim 1 , wherein the IPG sensor is configured to inject current at multiple frequencies into the patient's chest, and further configured to measure the current at multiple frequencies to determine the IPG waveform at multiple frequencies.

3 . The sensor of claim 1 , wherein the IPG sensor is configured to inject current at a single frequency into the patient's chest, and further configured to measure the current at the single frequency to determine the IPG waveform at the single frequency.

4 . The sensor of claim 1 , wherein the reflective optical sensor further includes a heating element.

5 . The sensor of claim 4 , wherein the heating element comprises a resistive heater.

6 . The sensor of claim 5 , wherein the resistive heater is a flexible film.

7 . The sensor of claim 1 , wherein the housing is of solid, unitary construction.

8 . The sensor of claim 1 , wherein the set of electrodes is a single electrode patch.

9 . A sensor for measuring a photoplethysmogram (PPG) waveform, a phonocardiogram (PCG) waveform, an impedance plethysmogram (IPG) waveform, and an electrocardiogram (ECG) waveform from a patient's chest, the sensor comprising:

a housing configured to be located on the patient's chest;

a reflective optical sensor for measuring the PPG waveform;

a digital microphone for measuring the PCG waveform;

a buzzer disposed in the housing, adjacent to the digital microphone, configured to generate an acoustic sound at a known amplitude and frequency;

a processor disposed within the housing; and

a set of electrodes that attach the optical sensor and the digital microphone to the patient's chest, with the set of electrodes connected to an ECG sensor configured to measure the ECG waveform,

wherein the set of electrodes is further attached to an IPG sensor, the IPG sensor configured to measure the IPG waveform,

wherein the digital microphone is configured to compare the acoustic sound generated by the buzzer with the PCG waveform to determine a quality of patient-sensor adhesion between the sensor and a surface of the patient's chest, and

wherein the processor uses time-domain analysis and frequency-domain analysis of the IPG waveform and uses time-domain analysis and frequency-domain analysis of the PCG waveform to collectively determine one of a coughing event, a wheezing event, and an apnea event by identifying amplitude modulation in the IPG waveform.

10 . The sensor of claim 9 , wherein the IPG waveform is one of time-domain bioimpedance waveform and a time-domain bioreactance waveform.

11 . The sensor of claim 9 , wherein the PCG waveform is a time-domain acoustic waveform.

12 . The sensor of claim 9 , wherein the IPG sensor is configured to inject current into the patient's chest, and further configured to measure the current to determine the IPG waveform.

13 . The sensor of claim 12 , wherein the IPG sensor is configured to inject current at multiple frequencies into the patient's chest, and further configured to measure the current at multiple frequencies to determine the IPG waveform at multiple frequencies.

14 . The sensor of claim 12 , wherein the IPG sensor is configured to inject current at a single frequency into the patient's chest, and further configured to measure the current at the single frequency to determine the IPG waveform at the single frequency.

15 . The sensor of claim 9 , wherein the reflective optical sensor further includes a heating element.

16 . The sensor of claim 15 , wherein the heating element comprises a resistive heater.

17 . The sensor of claim 16 , wherein the resistive heater is a flexible film.

18 . The sensor of claim 9 , wherein the housing is of solid, unitary construction.

19 . The sensor of claim 9 , wherein the set of electrodes is a single electrode patch.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2021
From: DHILLON, MARSHAL; DHILLON, MARK; TANG, ERIK; HAYWARD, LAUREN NICOLE MILLER; BANET, MATTHEW; MCCANNA, JAMES
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 055447/0381 →
Continuity (2)
Provisional Application 62845097 · May 8, 2019
Related Publication 20200352510A1 · Nov 12, 2020
References Cited (44)
US 3797129A · Ravin · 1974 [cited by examiner]
US 6168568B1 · Gavriely · 2001 [cited by examiner]
US 8427181B2 · Chetelat et al. · 2013 [cited by applicant]
US 9770190B2 · Herscovici-Cohen et al. · 2017 [cited by applicant]
US 11607152B2 · Moon et al. · 2023 [cited by applicant]
US 20040133079A1 · Mazar · 2004 [cited by examiner]
US 20090076410A1 · Libbus et al. · 2009 [cited by applicant]
US 20100268113A1 · Bieberich · 2010 [cited by examiner]
US 20110092857A1 · Herscovici-Cohen · 2011 [cited by examiner]
US 20110125044A1 · Rhee · 2011 [cited by examiner]
US 20150164340A1 · Bedingham · 2015 [cited by examiner]
US 20180064390A1 · Thakur · 2018 [cited by examiner]
US 20180199824A1 · Centen · 2018 [cited by examiner]
US 20180353134A1 · Walter · 2018 [cited by examiner]
US 20190133488A1 · Meftah · 2019 [cited by examiner]
US 20190239819A1 · Chang · 2019 [cited by examiner]
US 20190343480A1 · Shute · 2019 [cited by examiner]
US 20200121200A1 · Landesberg · 2020 [cited by examiner]
US 20200352510A1 · Dhillon et al. · 2020 [cited by applicant]
CN 102014737A · 2011 [cited by applicant]
CN 104114089A · 2014 [cited by applicant]
JP 2001505085A · 2001 [cited by applicant]
JP 2011516109A · 2011 [cited by applicant]
JP 2011522582A · 2011 [cited by applicant]
WO WO2009136341A2 · 2009 [cited by applicant]
WO WO9814116A2 · 2017 [cited by applicant]
WO WO2017214198A1 · 2017 [cited by examiner]
WO WO2017047402 · 2018 [cited by applicant]
WO 2020227641A1 · 2020 [cited by applicant]
T. W. Jones, et al. Bioreactance is a reliable method for estimating cardiac output at rest and during exercise, BJA: British Journal of Anaesthesia, vol. 115, Issue 3, Sep. 2015, pp. 386-391, https://doi.org/10.1093/bj… [cited by examiner]
Lozano A, Rosell J, Pallás-Areny R. Two-frequency impedance plethysmograph: real and imaginary parts. Med Biol Eng Comput. Jan. 1990;28(1):38-42. doi: 10.1007/BF02441675. PMID: 2325449. (Year: 1990). [cited by examiner]
Preliminary Report on Patentability for related International Application No. PCT/US2020/032125; report dated Nov. 18, 2021; (14 pages). [cited by applicant]
Lozano A et al: “Two-Frequency Impedance Plethysmograph: Real and Imaginary Parts”; Medical and Biological Engineering and Computing, Springer, Heildelberg, DE; vol. 28, No. 1; (5 pages). [cited by applicant]
International Search Report and Written Opinion for related International Application No. PCT/US2020/032125; action dated Aug. 4, 2020; (21 pages). [cited by applicant]
Communication pursuant to Article 94(3) EPC received in Application No. 20 729 425.7-1113, dated Oct. 16, 2023. [cited by applicant]
Chinese First Office Action mailed Sep. 18, 2023 in Application No. 202080033288.6, with English Translation. [cited by applicant]
Canadian First Office Action mailed Oct. 27, 2023 in Application No. 3,138,649. [cited by applicant]
Lozano et al., “Two-frequency impedance plethysmograph: real and imaginary parts Medical & Biological Engineering & Computing”, vol. 28, No. 1; pp. 38-42. [cited by applicant]
Notice of Reasons for Rejection mailed Mar. 26, 2024 in JP2021-562138. [cited by applicant]
Japanese Office Action mailed Aug. 23, 2024 in Application No. JP 2021-562138 with English language translation. [cited by applicant]
Mexican Office Action mailed Jul. 11, 2024 in Application No. MX/a/2021/013633. [cited by applicant]
English Summary of Mexican Office Action in Application No. MX/a/2021/013633. [cited by applicant]
Examination Report for related Australian Application No. 2020267599; action dated Oct. 23, 2024; (5 pages). [cited by applicant]
Examination report No. 2, Australian Application No. 2020267599, dated Feb. 5, 2025. [cited by applicant]